Table 5. The status of miRNAs from the first group which affect the CD3G gene responsible for the CD3-gamma subunit in cancer tissues relative to adjacent normal tissues.
miR-ID | Profile | Cancer | reference |
Has-miR-378 | down-regulated | bladder cancer | [41] |
down-regulated | carcinoma basal cells | [42] | |
down-regulated | CRC tumor | [43] | |
down-regulated | oral carcinoma | [44] | |
down-regulated | laryngeal cancer | [45] | |
down-regulated | stomach neoplasm | [46] | |
Has-miR-422a | down-regulated | laryngeal neoplasm | [45] |
down-regulated | colorectal neoplasm | [43] | |
Has-miR-593 | down-regulated | esophageal cancer (EC) | [47] |
Has-miR-494 | down-regulated | cholangio carcinoma (CCA), | [48] |
down-regulated | lung cancer | [49] | |
down-regulated | gastrointestinal neoplasm | [50] | |
Has-miR-515 | up-regulated | oral squamous cell carcinoma | [44] |
Has-miR-136 | up-regulated | lung neoplasm | [51] |